Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that the last ...
BMJ Global Health

How do repeated financial incentives affect HIV care-seeking behaviours over time? Evidence from a cluster-randomised controlled trial

Background A more nuanced understanding of behavioural responses to incentives over time, particularly after they are removed, could guide more effective interventions. In this study, we build on the ...
The Lancet

Universal school-based transdiagnostic interventions to improve mental health and wellbeing among Chinese adolescents: a two-group, cluster-randomised controlled trial

The reduction in depression and anxiety symptoms 3 months after completing ten AMHSP sessions indicates a slow but meaningful benefit of the programme and supports the potential of a low-intensity, ...
eLife

Temporal dynamics of peri-microsaccadic modulations within the foveola

Stearns and Poletti present a technically impressive study that aims to uncover a deeper understanding of microsaccade function: their role in perceptual modulation and the associated temporal ...

Ardelyx, Inc. (ARDX) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 19, 2026 4:30 PM ESTCompany ParticipantsCaitlin Lowie - Vice President of Corporate Communications ...